Generic Name
Dicyclomine
FDA approval date: September 30, 1974
Classification: Anticholinergic
Form: Injection, Tablet, Capsule, Solution
What is Dicyclomine?
Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine is an antispasmodic and anticholinergic agent indicated for the treatment of functional bowel/irritable bowel syndrome
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment